Akanda Corp. (NASDAQ:AKAN – Get Free Report) saw a large decline in short interest in January. As of January 15th, there was short interest totaling 74,784 shares, a decline of 50.6% from the December 31st total of 151,372 shares. Based on an average daily trading volume, of 780,682 shares, the short-interest ratio is presently 0.1 days. Approximately 103.9% of the shares of the stock are sold short. Approximately 103.9% of the shares of the stock are sold short. Based on an average daily trading volume, of 780,682 shares, the short-interest ratio is presently 0.1 days.
Akanda Stock Performance
Shares of NASDAQ AKAN opened at $1.53 on Thursday. The stock’s fifty day simple moving average is $3.15 and its 200 day simple moving average is $11.17. Akanda has a 52-week low of $1.19 and a 52-week high of $46.45.
Analyst Upgrades and Downgrades
AKAN has been the subject of several research reports. Wall Street Zen raised Akanda to a “sell” rating in a research note on Saturday, October 18th. Weiss Ratings restated a “sell (e+)” rating on shares of Akanda in a research report on Monday, January 12th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Sell”.
About Akanda
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.
Further Reading
- Five stocks we like better than Akanda
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for Akanda Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akanda and related companies with MarketBeat.com's FREE daily email newsletter.
